In the preceding three months, 10 analysts have released ratings for Merck & Co (NYSE:MRK), presenting a wide array of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 7 | 1 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 2 | 3 | 1 | 0 | 0 |
| 2M Ago | 0 | 3 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $137.2, with a high estimate of $148.00 and a low estimate of $130.00. This upward trend is apparent, with the current average reflecting a 6.63% increase from the previous average price target of $128.67.
Diving into Analyst Ratings: An...
Login or create a forever free account to read this news
Sign up/Log in